Search clinical trials for: ziftomenib

Total 17 results

Kura Oncology, Inc.

Available

Expanded Access to Ziftomenib

Acute Myeloid Leukemia, With NPM1 Mutations | Acute Lymphoblastic Leukemia, With KMT2A Rearrangements | Acute Myeloid Leukemia, With KMT2A Rearrangements
Kura Oncology, Inc.

Not yet recruiting

Bioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDS

Myeloid Leukemia, Acute | Myelodysplastic Syndrome (MDS)/AML
Kyowa Kirin Co., Ltd.

Recruiting

A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)

Japan
Massachusetts General Hospital
Bristol-Myers Squibb; Kura Oncology, Inc.

Not yet recruiting

Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

KMT2A-rearranged | NPM1-mutant Refractory or Relapsed AML

United States
Kura Oncology, Inc.

Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML)

United States, Australia, Czechia, Spain, Greece, Germany, Belgium, Italy, South Korea, France, Philippines, Portugal, Taiwan, Canada, Poland, United Kingdom

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe